Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th September, 2025 as attached.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ishita Drugs & Industries has submitted a routine compliance certificate to BSE for the quarter ended 30 September 2025. The certificate, issued by their Registrar and Share Transfer Agent (Bigshare Services Pvt Ltd), confirms that all share dematerialisation requests received from depository participants during the quarter were properly processed — accepted or rejected — and that the corresponding physical certificates were cancelled after verification. The names of the depositories have been substituted as the registered owners in the company's member register within the 15-day SEBI-mandated timeline. The filing was signed by Managing Director Jagdish Agrawal on 8 October 2025.
This is a standard procedural filing with no material impact on the business, financials, or stock price. It simply confirms that the company's share transfer and demat processes are running in compliance with SEBI rules.